• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

3.325 -0.065 (-1.92%)
Streaming Delayed Price Updated: 2:31 PM EDT, Apr 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,386,544
Open 3.330
Bid (Size) 3.320 (14,100)
Ask (Size) 3.330 (12,300)
Prev. Close 3.390
Today's Range 3.270 - 3.440
52wk Range 2.800 - 7.180
Shares Outstanding 168,425,907
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Recursion to Participate in Upcoming Investor Conferences
April 07, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
April 06, 2026
In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a... 
Via MarketMinute
Topics Artificial Intelligence

Performance

YTD
-20.8%
-20.8%
1 Month
-5.3%
-5.3%
3 Month
-31.6%
-31.6%
6 Month
-45.4%
-45.4%
1 Year
-16.2%
-16.2%

More News

Read More
News headline image
1 Beaten-Down AI Stock to Buy and 1 to Avoid ↗
April 01, 2026
Via The Motley Fool
Topics Artificial Intelligence
Recursion Pharmaceuticals (NASDAQ:RXRX) Soars on Q4 Earnings Beat ↗
February 25, 2026
Via Chartmill
News headline image
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
March 31, 2026
From Citeline
Via GlobeNewswire
News headline image
2 AI Healthcare Stocks to Buy Right Now ↗
March 31, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
March 25, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Prediction: The "Trough of Disillusionment" Will Create the Best Buying Opportunity for Artificial Intelligence (AI) Stocks in 2026 ↗
March 22, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗
March 21, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Can This AI Stock Bounce Back in 2026? ↗
March 08, 2026
Via The Motley Fool
Topics Animal Testing Artificial Intelligence
News headline image
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
February 26, 2026
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Recursion (RXRX) Q4 2025 Earnings Call Transcript ↗
February 25, 2026
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
What's Behind The Jump In Recursion Pharmaceuticals Stock? ↗
February 25, 2026
Via Benzinga
News headline image
RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
February 25, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
February 23, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion to Participate in Upcoming Investor Conferences
February 23, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
February 22, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges ↗
February 19, 2026
Via MarketBeat
Topics Artificial Intelligence
News headline image
Recursion Pharmaceuticals Stock Drops: What's Behind It? ↗
February 18, 2026
Via Benzinga
News headline image
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
February 18, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
February 17, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
February 12, 2026
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
This $4 Stock Could Be Your Ticket to Millionaire Status ↗
February 07, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions
February 06, 2026
Via TokenRing AI
Topics Artificial Intelligence

Frequently Asked Questions

Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.325
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 04/09/26 02:31 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 560.02M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 560M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap